Imugene Limited ( IUGNF) - Key Metrics
IUGNF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.19 | -$0.05 | -$0.05 |
| 2026Q2 | $0 | -$0.13 | -$0.09 | -$0.09 |
| 2025Q4 | $0.01 | -$0.09 | -$0.17 | -$0.15 |
| 2025Q2 | $0.01 | -$0.22 | -$0.18 | -$0.23 |
| 2024Q4 | -$0.01 | -$0.38 | -$0.23 | -$0.22 |
IUGNF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -0.19 |
| 2026Q2 | 0% | -0.75 |
| 2025Q4 | 0% | -1.37 |
| 2025Q2 | 0% | -1.34 |
| 2024Q4 | 0% | -1.37 |
IUGNF
Price: $0.06
52 week price:
Earnings Per Share: -0.23 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.2 million